Long-term human data beyond 6 months remains limited, but preclinical toxicology studies in animals showed no concerning findings with chronic administration
These properties make BPC 157 popular in sports medicine and rehabilitation for supporting recovery from injuries or surgery
Cagrilintide's amylin mechanism (different pathway) How cagrilintide works: Amylin receptor agonist Long-acting weekly injection Investigational (not FDA approved) Different receptors than GIP/GLP-1 Amylin pathway effects: Very strong gastric emptying delay (stronger than GLP-1) Central appetite suppression (area postrema) Reduces meal frequency Suppresses glucagon Enhances satiety Cagrilintide monotherapy results: 10-12% average body weight loss Significant GI side effects (stronger gastric slowing) Currently in Phase 3 trials Not yet available pharmaceutically See our cagrilintide weight loss , cagrilintide dosing , and cagrilintide and semaglutide guides
At CoLaz, B12 injections are given by trained clinicians after a written consultation, and we will tell you when a GP visit and blood test should come first
Simple notes about subjective experience, objective measurements, and any concerns enable informed decisions about continuing, adjusting, or discontinuing individual components